# GWLL (Goldenwell Biotech, Inc.) - SEC EDGAR Financial Statements

> Goldenwell Biotech, Inc. reported $55 in revenue and a net loss of $286K for the trailing twelve months ended September 30, 2026 (down 60.4% year over year), with a 21.8% gross margin and a -215356.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/GWLL
- Markdown: https://convexityos.com/fundamentals/GWLL.md
- SEC CIK: 0001800373
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:52 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001800373&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $55 | -60.4% YoY |
| Operating Income | TTM | -$118K | -215356.4% margin |
| Net Income | TTM | -$286K | -519567.3% net margin |
| Diluted EPS | TTM | -$0.00 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $55 | $139 | $1.8K | $48K | $16K | $0 | $0 |
| Cost of Revenue | $43 | $75 | $1.2K | $23K | $7.6K | $0 | $0 |
| **Gross Profit** | $12 | $64 | $666 | $25K | $8.4K | $0 | $0 |
| Selling, General & Admin | -- | -- | -- | -- | $127K | $6.4K | $2.6K |
| Total Operating Expenses | $113K | $123K | $116K | $1.01M | -$127K | $6.4K | $2.6K |
| **Operating Income** | -$113K | -$123K | -$116K | -$985K | -$118K | -$6.4K | -$2.6K |
| Interest Expense | $8.4K | $8.4K | $1.5K | -- | $0 | $0 | $0 |
| Income Before Tax | -- | -$131K | -$117K | -- | -$118K | -$6.4K | -$2.6K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$296K | -$131K | -$117K | -$985K | -$117K | -$6.3K | -$2.3K |
| Basic EPS | -- | -- | -- | -- | $0.00 | $0.00 | $0.00 |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | -- | -- | -- | -- | 91.3M | 80.0M | 76.2M |
| Diluted Shares Outstanding | 99.0M | 99.0M | 99.0M | -- | 91.3M | 80.0M | 76.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $55 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 | $43 | $0 | $0 | $0 | $0 |
| **Gross Profit** | $0 | $0 | $0 | $12 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $29K | $35K | $31K | $23K | $26K | $28K | $36K | $25K |
| **Operating Income** | -$29K | -$35K | -$31K | -$23K | -$26K | -$28K | -$36K | -$25K |
| Interest Expense | -- | -- | $2.1K | $2.1K | $2.1K | $2.1K | $2.1K | $2.1K |
| Income Before Tax | -- | -- | -- | -- | -- | -- | -$34K | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$32K | -$37K | -$18K | -$200K | -$28K | -$30K | -$39K | -$27K |
| **Diluted EPS** | -- | $0.00 | $0.00 | $0.00 | -- | -- | $0.00 | $0.00 |
| Diluted Shares Outstanding | 99.0M | 99.0M | 99.0M | 99.0M | 99.0M | 99.0M | 99.0M | 99.0M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | $53K | $46K | $214K | $249K | $247K |
| **Cash & Short-Term Investments** | -- | -- | $53K | $46K | $214K | $249K | $247K |
| Accounts Receivable, Net | -- | $0 | $0 | $0 | $0 | -- | -- |
| Inventory | $175K | $175K | $175K | $176K | $199K | $0 | -- |
| **Total Current Assets** | -- | -- | -- | -- | -- | -- | $247K |
| Intangible Assets | -- | -- | -- | -- | -- | $0 | $0 |
| **Total Non-Current Assets** | -- | -- | -- | -- | -- | -- | $0 |
| **Total Assets** | $36K | $224K | $228K | $248K | $461K | $249K | $247K |
| Accounts Payable | $0 | $0 | $0 | $0 | $111K | $0 | -- |
| Deferred Revenue (Current) | $1.9K | $0 | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $102K | $1.9K | -- | -- | $159K | $0 | $0 |
| Long-Term Debt | -- | $174K | $46K | -- | -- | -- | -- |
| Other Non-Current Liabilities | $189K | $189K | $70K | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $323K | $270K | -- | $20K | $0 | $0 | $0 |
| **Total Liabilities** | $425K | $271K | $144K | $47K | $159K | $0 | $0 |
| **Total Debt (incl. Leases)** | -- | $174K | $46K | $25K | $48K | -- | -- |
| Common Stock | $9.9K | $9.9K | $9.9K | $9.9K | $9.6K | $9.2K | $8.0K |
| Retained Earnings | -$1.66M | -$1.36M | -$1.23M | -$1.11M | -$126K | -$8.6K | -$2.3K |
| **Total Stockholders' Equity** | -$344K | -$47K | $84K | $202K | $302K | $249K | $247K |
| Total Equity | -$344K | -$47K | $84K | $202K | $302K | $249K | $247K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Accounts Receivable, Net | -- | -- | $0 | -- | $0 | $0 | -- | $0 |
| Inventory | -- | $0 | $0 | $175K | $175K | $175K | $175K | $175K |
| **Total Assets** | $15K | $29K | $19K | $36K | $220K | $251K | $192K | $224K |
| Accounts Payable | -- | $0 | $0 | $0 | $0 | $0 | -- | $0 |
| Deferred Revenue (Current) | -- | $0 | $100K | $1.9K | $38K | $62K | -- | $0 |
| **Total Current Liabilities** | $100K | $100K | $100K | $102K | $39K | $64K | -- | $1.9K |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | $176K | $174K |
| Other Non-Current Liabilities | $189K | $189K | $189K | $189K | $189K | $189K | $189K | $189K |
| **Total Non-Current Liabilities** | $344K | $327K | $280K | $323K | $276K | $274K | -- | $270K |
| **Total Liabilities** | $444K | $427K | $380K | $425K | $315K | $338K | $274K | $271K |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | -- | $176K | $174K |
| Common Stock | $9.9K | $9.9K | $9.9K | $9.9K | $9.9K | $9.9K | $9.9K | $9.9K |
| Retained Earnings | -$1.74M | -$1.71M | -$1.67M | -$1.66M | -$1.41M | -$1.40M | -$1.39M | -$1.36M |
| **Total Stockholders' Equity** | -$430K | -$398K | -$361K | -$344K | -$144K | -$116K | -$86K | -$47K |
| Total Equity | -$430K | -$398K | -$361K | -$344K | -$144K | -$116K | -$86K | -$47K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$296K | -$131K | -$117K | -$985K | $117K | -$6.3K | -$2.3K |
| Change in Receivables | -- | -- | $0 | $0 | $0 | -- | -- |
| Change in Inventory | $43 | $75 | $1.2K | -$23K | -$199K | $0 | -- |
| Change in Payables | -- | -- | -- | -$111K | $111K | $0 | -- |
| **Operating Cash Flow** | -$23K | -$123K | -$113K | -$1.07M | -$205K | -$6.3K | -$2.3K |
| Common Stock Issued | -- | -- | $0 | $300 | $92K | $8.3K | $249K |
| **Financing Cash Flow** | $0 | $119K | $120K | $905K | $170K | $8.3K | $249K |
| **Net Change in Cash** | -$23K | -$3.8K | $7.2K | -$168K | -$35K | $2.0K | $247K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$32K | -$37K | -$18K | -$200K | -$28K | -$30K | -$39K | -$27K |
| Change in Receivables | -- | $0 | $0 | -- | $0 | $0 | $0 | -- |
| Change in Inventory | $0 | $0 | $175K | $43 | $0 | $0 | $0 | -$73 |
| Change in Payables | -- | $0 | $0 | -- | $0 | $0 | $0 | -- |
| **Operating Cash Flow** | -$25K | -$47K | -$13K | -$19K | -$31K | $59K | -$32K | -$25K |
| Common Stock Issued | -- | $0 | $0 | -- | $0 | $0 | $0 | -- |
| **Financing Cash Flow** | $15K | $45K | $0 | $0 | $0 | $0 | $0 | $70K |
| **Net Change in Cash** | -$10K | -$2.3K | -$13K | -$19K | -$31K | $59K | -$32K | $45K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 21.8% | 46.0% | 36.3% | 52.7% | 52.5% | -- | -- |
| **Operating Margin** | -206047.3% | -88559.7% | -6308.6% | -2060.9% | -740.7% | -- | -- |
| **Net Profit Margin** | -539038.2% | -94602.9% | -6392.2% | -2060.9% | -732.6% | -- | -- |
| Return on Equity (ROE) | -- | -- | -139.3% | -488.6% | -38.8% | -2.5% | -0.9% |
| Return on Assets (ROA) | -820.8% | -58.7% | -51.5% | -396.6% | -25.4% | -2.5% | -0.9% |
| Quick Ratio | -- | -- | -- | -- | 1.34x | -- | -- |
| Debt to Equity | -- | -- | 0.55x | 0.13x | 0.16x | -- | -- |
| **Revenue Growth (YoY)** | -60.4% | -92.4% | -96.2% | +199.4% | -- | -- | -- |
| Gross Profit Growth (YoY) | -81.2% | -90.4% | -97.4% | +200.3% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 21.8% | 21.8% | 21.8% | 21.8% | -- | -- | 50.4% | 50.4% |
| **Operating Margin** | -215356.4% | -208729.1% | -196772.7% | -206047.3% | -- | -- | -93937.4% | -88556.1% |
| **Net Profit Margin** | -519567.3% | -512940.0% | -500983.6% | -539038.2% | -- | -- | 5033.8% | 55043.2% |
| Return on Assets (ROA) | -1965.6% | -973.6% | -1469.2% | -820.8% | -56.3% | -29.1% | 3.6% | 34.1% |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -100.0% | -- | -100.0% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -100.0% | -- | -100.0% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -220.9% | -160.7% | -224.4% | -- |
| Operating Cash Flow Growth (YoY) | -- | -179.6% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
